Skip to main content

Diabetes and Doping

  • Chapter
  • First Online:
Book cover Type 1 Diabetes

Abstract

When humans are placed in a competitive setting, particularly in the sporting arena, they will attempt to gain an advantage over their opponent in order to win. When all legitimate methods have been exhausted and the athlete has reached their peak performance, there is a temptation for some to seek out pharmacological methods to improve performance yet further. Doping not only damages the integrity of sport but may cause significant harm to athletes who use performance-enhancing drugs, including athletes with type 1 diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Holt RI, Erotokritou-Mulligan I, Sonksen PH. The history of doping and growth hormone abuse in sport. Growth Horm IGF Res. 2009;19(4):320–6.

    Article  PubMed  CAS  Google Scholar 

  2. Yesalis CE, Bahrke MS. History of doping in sport. In: Bahrke MS, Yessalis CE, editors. Performance-enhancing substances in sport and exercise. 1st ed. Champaign: Human kinetics; 2002. p. 1–20.

    Google Scholar 

  3. Wilson JD. Androgen abuse by athletes. Endocr Rev. 1988;9(2):181–99.

    Article  PubMed  CAS  Google Scholar 

  4. Bagatell CJ, Bremner WJ. Androgens in men–uses and abuses. N Engl J Med. 1996;334(11):707–14.

    Article  PubMed  CAS  Google Scholar 

  5. Geraci MJ, Cole M, Davis P. New onset diabetes associated with bovine growth hormone and testosterone abuse in a young body builder. Hum Exp Toxicol. 2011;30(12):2007–12.

    Google Scholar 

  6. Sawka MN, Muza SR, Young AJ. Erythrocyte volume expansion and human performance. In: Fourcroy JL, editor. Pharmacology, doping and sports. a scientific guide for athletes, physicians, scientists and administrators. Abingdon: Routledge; 2009. p. 125–34.

    Google Scholar 

  7. Fernandez-Reyes MJ, Selgas R, Bajo MA, Jimenez C, Del PG, Sanchez MC, et al. Increased response to subcutaneous erythropoietin on type I diabetic patients on CAPD: is there a synergistic effect with insulin? Perit Dial Int. 1995;15(6):231–5.

    PubMed  CAS  Google Scholar 

  8. Liu H, Bravata DM, Olkin I, Friedlander A, Liu V, Roberts B, et al. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med. 2008;148(10):747–58.

    PubMed  Google Scholar 

  9. Guha N, Sonksen PH, Holt RI. IGF-I abuse in sport: current knowledge and future prospects for detection. Growth Horm IGF Res. 2009;19(4):408–11.

    Article  PubMed  CAS  Google Scholar 

  10. Holt RI, Sonksen PH. Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol. 2008;154(3):542–56.

    Article  PubMed  CAS  Google Scholar 

  11. Acerini CL, Patton CM, Savage MO, Kernell A, Westphal O, Dunger DB. Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Lancet. 1997;350(9086): 1199–204.

    Article  PubMed  CAS  Google Scholar 

Further Reading Books

  • Fainaru-Wada M, Gotham LW. Game of shadows: Barry Bonds, BALCO, and the steroids scandal that rocked professional sports. 1st ed. 2006; pp. 352. ISBN-10: 9781592401994.

    Google Scholar 

  • Fourcroy JL. Pharmacology, doping and sports: a scientific guide for athletes, coaches, physicians, scientists and administrators. 1st ed. Routledge; 2008, pp. 240. ISBN-10: 0415578221.

    Google Scholar 

Themed Journal Issues

  • McGrath I, Cowan D, Guest Editors. Drugs in sport. Br J Pharmacol. 2008; 154(3).

    Google Scholar 

  • Sonksen PH, Holt RIG, Guest Editors. The abuse of growth hormone in sport and its detection: a medical, legal and social framework. Growth Hormone IGF Res. 2009;(4).

    Google Scholar 

Useful Websites

Download references

Acknowledgments

I would like to thank Michael Stow of UK Anti-Doping for his helpful comments on the chapter.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard I. G. Holt M.A., M.B., B.Chir., Ph.D., FRCP, FHEA .

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London

About this chapter

Cite this chapter

Holt, R.I.G. (2012). Diabetes and Doping. In: Type 1 Diabetes. Springer, London. https://doi.org/10.1007/978-0-85729-754-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-754-9_8

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-753-2

  • Online ISBN: 978-0-85729-754-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics